10.4149/neo_2022_221007N992 121 MinY
Emerging nanotechnology platforms offer unprecedented precision in ferroptosis modulation
Notably, ATO-VAC showed substantial therapeutic potential, as the administration of this vaccine to TC-1 cell-bearing mice significantly reduced tumor growth
Key Points L-Arginine is the substrate of endothelial nitric oxide synthase and the main precursor of nitric oxide in the vascular endothelium Evidence indicates that intra-arterial or intravenous infusion of L-arginine rapidly improves nitric oxide bioavailability in the coronary arteries in both animal models and humans Oral treatment with L-arginine seems to improve endothelial function in high-risk patients, but this effect is not observed in healthy individuals, or in patients with coronary atherosclerosis or myocardial infarction who are receiving optimum medical treatment Although L-arginine is not associated with any serious adverse effects, there is still no conclusive evidence for its use for primary or secondary prevention of adverse cardiovascular events This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
Oxidative stress Multiple preclinical findings have demonstrated that LAN exposure induces oxidative stress responses, leading to the accumulation of reactive oxygen species (ROS), DNA damage, and altered expression of oxidative stress-related genes 60,61,62
Cangut, B, Sakowitz, S, Rajah, T, Papageorge, MV, Boyd, R, Lin, N, Stanley, M, Blackmon, SH, Molena, D, Watkins, AA, Worrell, SG, Antonoff, MB
